Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01855126
Other study ID # R01AG042602
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2013
Est. completion date April 2017

Study information

Verified date January 2019
Source Rensselaer Polytechnic Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In conjunction with investigators at the Cecil G. Sheps Center for Health Services Research, University of North Carolina (UNC) at Chapel Hill, we propose to develop and evaluate a low-cost, minimally obtrusive device that delivers individualized light therapy to adults with early-awakening insomnia - the most common sleep disturbance in older adults, and a significant problem because of its relationship to daytime sleepiness, use of potentially hazardous sleep medication, and reduced quality of life. The proposed device will measure light/dark exposure data over 24 hours, estimate optimum timing for light delivery, and deliver an individualized light dosage while subjects are asleep. Light applied through closed eyelids in the early part of the night will delay the dim light melatonin onset, a marker of the circadian clock, and help those with early sleep onset to fall asleep later


Description:

We will recruit 50 subjects who report going to bed early and desiring later bedtimes and will ask them to wear an active and an inactive light mask for 8 consecutive weeks each. A 2-week washout period between active and inactive conditions will be applied. Outcome measures will be collected periodically throughout the 8 weeks. Baseline (no intervention) will be collected prior to the active and inactive lighting interventions.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date April 2017
Est. primary completion date April 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- age 65 or older

- cognitively capable

- able to respond to study staff verbally and in English

- score greater than 6 using the Pittsburgh Sleepiness Quality Index

- suffer from insomnia

- suffer from excessive daytime sleepiness

Exclusion Criteria:

- Severe sleep apnea

- Severe restless leg syndrome (RLS)

- Significant cognitive impairment

- History of severe photosensitivity dermatitis

Study Design


Intervention

Other:
Blue light
After a two week baseline collection period, half of the subjects will initially be given light masks that deliver blue light through the closed eyelids, while subjects are sleeping. The light mask will always be turned on 120 min before estimated core body temperature minimum (CBTmin); it is expected that blue light exposure will delay the timing of the CBTmin.
Red light
After a two week baseline collection period, half of the subjects will initially be given light masks that deliver red light through the closed eyelids, while subjects are sleeping. The light mask will always be turned on 120 min before estimated core body temperature minimum (CBTmin); it is expected that red light exposure will have no effect on the timing of the CBTmin.

Locations

Country Name City State
United States Rensselaer Polytechnic Institute Troy New York

Sponsors (2)

Lead Sponsor Collaborator
Rensselaer Polytechnic Institute University of North Carolina

Country where clinical trial is conducted

United States, 

References & Publications (2)

Figueiro MG, Bierman A, Rea MS. A train of blue light pulses delivered through closed eyelids suppresses melatonin and phase shifts the human circadian system. Nat Sci Sleep. 2013 Oct 4;5:133-41. doi: 10.2147/NSS.S52203. eCollection 2013. — View Citation

Figueiro MG, Plitnick B, Rea MS. Pulsing blue light through closed eyelids: effects on acute melatonin suppression and phase shifting of dim light melatonin onset. Nat Sci Sleep. 2014 Dec 2;6:149-56. doi: 10.2147/NSS.S73856. eCollection 2014. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Sleep Disturbance Pittsburgh Sleep Quality Index. Score range 0 - 21. A score over 5 is indicative of sleep disturbance.
Change in score from baseline to intervention is reported. A larger difference indicates a better outcome.
Baseline (week 0) and week 8 of lighting intervention
Primary Total Sleep Time The change in total amount of minutes spent sleeping at night from baseline week to the last week of intervention. A higher number is an improved outcome baseline week (week 0) and the last week of intervention (week 8)
Primary Sleep Efficiency The change in sleep efficiency from baseline to last week of intervention. A higher number is a better outcome. Sleep efficiency is the percentage of time spent in bed sleeping. Scored total sleep time divided by interval duration minus total invalid time (sleep/wake) of the given rest interval multiplied by 100. This data was collected using actigraphy data. baseline week (week 0) and the last week of intervention (week 8)
Primary Sleep Start Time Change in sleep start time, in minutes, from baseline week to the last week of intervention. A higher number is a better outcome. Based on actigraph data baseline week (week 0) and the last week of intervention (week 8)
See also
  Status Clinical Trial Phase
Completed NCT01942733 - Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder Phase 3
Recruiting NCT05212298 - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus N/A
Not yet recruiting NCT02245594 - GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease Phase 0
Completed NCT01442610 - Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease Phase 4
Recruiting NCT03942341 - Sleep in Adults With Down Syndrome and Alzheimer's Disease
Recruiting NCT01966835 - Effect of Moderate to High Intensity Aerobic Interval Training on Polysomnographic Measured Sleep in Patients With Rheumatoid Arthritis N/A
Recruiting NCT05827575 - Transcutaneous Auricular Vagal Nerve Stimulation for Functional Dyspepsia With Sleep Disturbances: a Randomized Controlled Trial N/A
Not yet recruiting NCT02477735 - The Effect of Tympanostomy Tube Insertion on Sleep in Children With Chronic Otitis Media With Effusion N/A
Recruiting NCT01816152 - Methodology Issues in a Tailored Light Treatment for Persons With Dementia N/A
Recruiting NCT01907711 - Clinical Trial to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed With CFS. Phase 2/Phase 3
Recruiting NCT02541318 - Study of Effects of Dao-In Exercise on the Perimenopausal Women With Sleep Disturbance N/A
Completed NCT02194036 - Learning Oriented Physiotherapy - a New Approach N/A
Completed NCT01429636 - Applied Relaxation (AR) Technique Versus Its Modified Version for Treating Menopausal Symptoms Phase 3
Recruiting NCT01032473 - Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD) N/A
Recruiting NCT05234125 - Better Lifestyle Counseling for African American Women During Pregnancy N/A
Completed NCT02360904 - A Yoga Program for Breast Cancer Patients Undergoing Chemotherapy N/A
Completed NCT01311193 - Circadian Sleep-wake Cycles and Light Therapy in Borderline Personality Disorder N/A